Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Cellectis S.A. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −5 vs. Q2 2023
- Shares held
- 11.5M
- −2.53M (−18.0%) vs. Q2 2023
- Total value
- $18.1M
- −$9.45M (−34.3%) vs. Q2 2023
- New holders
- 2
- 8 more added
- Sold out
- 7
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 56 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 10 | $10 | 0.00% | +8+400.0% | Added |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 28 | $44 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 31 | $49 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% | +40 | New |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% | +66+146.7% | Added |
| TD Waterhouse Canada Inc. | 360 | $540 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,755 | $4.35K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,970 | $4.69K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $5.35K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,035 | $6.38K | 0.00% | +4,035 | New |
| JPMorgan Chase & Co | 5,023 | $7.94K | 0.00% | +4,504+867.8% | Added |
| Advisor Group Holdings, Inc. | 8,970 | $14.2K | 0.00% | +3,605+67.2% | Added |
| Geode Capital Management, LLC | 10,776 | $17.0K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 10,944 | $17.3K | 0.00% | +9,727+799.3% | Added |
| Wells Fargo & Company | 15,544 | $24.6K | 0.00% | −375−2.4% | Reduced |
| Citadel Advisors LLC | 34,300 | $54.2K | 0.00% | +4,317+14.4% | Added |
| D. E. Shaw & Co., Inc. | 47,154 | $74.5K | 0.00% | −31,675−40.2% | Reduced |
| LPL Financial LLC | 63,657 | $100.6K | 0.00% | +49,650+354.5% | Added |
| Morgan Stanley | 67,592 | $106.8K | 0.00% | −9,560−12.4% | Reduced |
| Oppenheimer & Co Inc | 121,420 | $191.8K | 0.00% | +3,731+3.2% | Added |
| KBC Group NV | 163,447 | $258.0K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 226,875 | $358.0K | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 656,600 | $1.04M | 0.00% | −10,441−1.6% | Reduced |
| Millennium Management LLC | 1,095,966 | $1.73M | 0.00% | −71,675−6.1% | Reduced |
| Baillie Gifford & Co | 1,164,009 | $1.84M | 0.00% | −254,987−18.0% | Reduced |
| Credit Suisse AG | 1,438,255 | $2.27M | 0.00% | 00.0% | Unchanged |
| Capital International Investors | 1,848,804 | $2.92M | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 4,487,293 | $7.09M | 1.02% | 00.0% | Unchanged |
| Bpifrance SA | 0 | $0 | 0.00% | −2,186,960−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −27,841−100.0% | Sold out |
| One68 Global Capital, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −2,721−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −48−100.0% | Sold out |